Adaptimmune Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.

About ADAP

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8.

CEO

Adrian Rawcliffe

CEOAdrian Rawcliffe

Employees

506

Employees506

Headquarters

Abingdon, Oxfordshire

HeadquartersAbingdon, Oxfordshire

Founded

2014

Founded2014

Employees

506

Employees506

ADAP Key Statistics

Market cap

76.78M

Market cap76.78M

Price-Earnings ratio

-1.05

Price-Earnings ratio-1.05

Dividend yield

—

Dividend yield—

Average volume

637.82K

Average volume637.82K

High today

$0.313

High today$0.313

Low today

$0.281

Low today$0.281

Open price

$0.291

Open price$0.291

Volume

1.01M

Volume1.01M

52 Week high

$1.48

52 Week high$1.48

52 Week low

$0.1951

52 Week low$0.1951

Analyst ratings

50%

of 8 ratings

Buy

50%

Hold

37.5%

Sell

12.5%